Clinical Trial of Human Botulism Immune Globulin
A major theme of this conference is that botulinum toxin, nature’s most poisonous poison,1 has now been “tamed” and has acquired the distinction of becoming, through the work of Scott2 and Schantz,3 the first bacterial toxin to serve as a medicine for the betterment of humanity. So in this historic and felicitous context, it appears to be my unwelcome responsibility to remind this conference that botulinum toxin remains very much an adversary for certain select groups of patients, most notably, infants.4
KeywordsPlacebo Clay Europe Germinate Neurol
Unable to display preview. Download preview PDF.
- 4.Amon SS. Infant botulism. In: Feigin RD, Cherry JD, eds. Textbook of Pediatric Infectious Diseases, third edition. Philadelphia: WB Saunders, 1992:1095–1102 (ch. 107).Google Scholar
- 8.Centers for Disease Control. Summary of notifiable diseases, United States, 1990. Morbid Mortal Wkly Rept 1991; 39 (53): 56.Google Scholar
- 18.Lewis GE Jr, Metzger JF. Studies on the prophylaxis and treatment of botulism. In: Eaker D, Wadstrom T, eds. Textbook of Natural Toxins. New York: Pergamon Press, 1980: 601–606Google Scholar
- 19.Ember L. Chemical weapons: plan proposed to destroy Iraqi arms. Chem Eng News 1991; 69: 6.Google Scholar